{"id":"placebo-dlbs5055","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"aiSummary":"DLBS5055 is a placebo developed by Duta Wacana Christian University. As a placebo, it does not contain any active pharmaceutical ingredients and is used primarily in clinical trials to serve as a control for comparison with active treatments. The lack of an FDA label indicates that it has not been evaluated or approved by the regulatory body for any specific medical use. Since it is a placebo, it does not have a defined mechanism of action, approved indications, or specific safety concerns beyond those typically associated with placebo administration. Commercially, it is not expected to generate revenue, and there are no competitors or patent issues to consider.","mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a placebo, DLBS5055 contains no active pharmaceutical ingredient and produces no direct molecular or biological effect. It is used as a control comparator in clinical trials to assess the efficacy of active treatments through comparison against a non-therapeutic baseline. Any observed clinical benefit in placebo recipients would be attributable to placebo effect rather than drug action.","oneSentence":"Placebo DLBS5055 has no pharmacological mechanism of action, as it is an inert control substance.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:00:44.799Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"commercial":{"yoyGrowth":0,"launchDate":"Not applicable","annualCostUS":0,"currentRevenue":0,"patientPopulation":"Not applicable","peakSalesEstimate":0},"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT06100432","phase":"PHASE4","title":"Effect of Eurycoma Longifolia (DLBS5055) and Multivitamins (Vitamin C+Vitamin E+ Β-carotene) for Infertile Males","status":"ACTIVE_NOT_RECRUITING","sponsor":"Duta Wacana Christian University","startDate":"2023-11-11","conditions":"Male Infertility","enrollment":90}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo Herbapoten"],"phase":"marketed","status":"active","brandName":"Placebo DLBS5055","genericName":"Placebo DLBS5055","companyName":"Duta Wacana Christian University","companyId":"duta-wacana-christian-university","modality":"Small molecule","firstApprovalDate":"Not applicable","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}